The aforementioned result gave us the opportunity to speculate that the GSTO1*AA “anti-inflammatory” genotype protected the patients from developing diabetic nephropathy, the long-time existing complication of type 2 diabetes mellitus. Here, GSTO1 is linked to diabetic kidney disease.